BMY
Bristol-Myers Squibb Company
NYSE: BMY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$60.59
+5.21% today
Updated 2026-04-30
Market cap
$123.71B
P/E ratio
17.51
P/S ratio
2.57x
EPS (TTM)
$3.46
Dividend yield
4.32%
52W range
$41 – $62
Volume
12.1M
Bristol-Myers Squibb Company (BMY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
14.60%
Operating margin
28.20%
ROE
40.40%
ROA
10.30%
Debt/equity
2.55x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $17.91B | $1.58B | 65.22% | 14.75% | 8.85% |
| 2007 | $19.35B | $2.17B | 68.26% | 19.47% | 11.19% |
| 2008 | $20.60B | $5.25B | 70.11% | 23.67% | 25.47% |
| 2009 | $18.81B | $10.61B | 73.25% | 26.84% | 56.42% |
| 2010 | $19.48B | $3.10B | 73.55% | 31.49% | 15.92% |
| 2011 | $21.24B | $3.71B | 74.00% | 31.78% | 17.46% |
| 2012 | $17.62B | $1.96B | 74.84% | 24.22% | 11.12% |
| 2013 | $16.39B | $2.56B | 72.02% | 19.10% | 15.64% |
| 2014 | $15.88B | $2.00B | 75.57% | 19.74% | 12.62% |
| 2015 | $16.56B | $1.56B | 77.33% | 23.78% | 9.45% |
| 2016 | $19.43B | $4.46B | 74.61% | 26.66% | 22.94% |
| 2017 | $20.78B | $1.01B | 72.00% | 25.22% | 4.85% |
| 2018 | $22.56B | $4.92B | 71.25% | 28.34% | 21.81% |
| 2019 | $26.14B | $3.44B | 65.98% | 24.63% | 13.15% |
| 2020 | $42.52B | $-8.99B | 51.04% | 10.56% | -21.16% |
| 2021 | $46.38B | $6.99B | 57.69% | 20.57% | 15.08% |
| 2022 | $46.16B | $6.33B | 57.39% | 20.08% | 13.71% |
| 2023 | $45.01B | $8.03B | 56.34% | 18.82% | 17.83% |
| 2024 | $48.30B | $-8.95B | 56.80% | 20.00% | -18.53% |
| 2025 | $48.19B | $7.05B | 67.65% | 26.34% | 14.63% |